Primary Operation with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-Year Follow-Up of Protocol MF07-01 Randomized Clinical Trial.


Creative Commons License

Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., ...Daha Fazla

Journal of the American College of Surgeons, cilt.233, ss.742-752, 2021 (SCI-Expanded) identifier identifier identifier

Özet

BACKGROUND: The aim of this randomized clinical trial was to evaluate the overall survival (OS) data of patients diagnosed with de novo stage IV breast cancer (BC) who received locoregional treatment (LRT) over a 10-year follow-up.